Demyelination News and Research

RSS
A demyelinating disease is any disease of the nervous system in which the myelin sheath of neurons is damaged. This impairs the conduction of signals in the affected nerves, causing impairment in sensation, movement, cognition, or other functions depending on which nerves are involved.
Study: Certain inflammatory demyelinating diseases belong to different category than multiple sclerosis

Study: Certain inflammatory demyelinating diseases belong to different category than multiple sclerosis

'Chaperone protein' protects against autoimmune diseases, mice study shows

'Chaperone protein' protects against autoimmune diseases, mice study shows

Study sheds light on myelin's role in 'chemobrain' and multiple sclerosis

Study sheds light on myelin's role in 'chemobrain' and multiple sclerosis

Study shows how gene therapy may help protect against vision loss in multiple sclerosis

Study shows how gene therapy may help protect against vision loss in multiple sclerosis

A molecular switch for repairing damage in central nervous system disorders discovered

A molecular switch for repairing damage in central nervous system disorders discovered

Researchers demonstrate a novel method for treating multiple sclerosis

Researchers demonstrate a novel method for treating multiple sclerosis

The sympathetic nervous system can modulate action of defense cells in autoimmune disease

The sympathetic nervous system can modulate action of defense cells in autoimmune disease

Neuroscientists to introduce new approach to assess brain damage in Parkinson's patients

Neuroscientists to introduce new approach to assess brain damage in Parkinson's patients

Researchers one step closer to unmasking the cause of familial MS

Researchers one step closer to unmasking the cause of familial MS

Innovative compound offers a new therapeutic approach to treat multiple sclerosis

Innovative compound offers a new therapeutic approach to treat multiple sclerosis

Study reveals mechanism behind failed remyelination in MS

Study reveals mechanism behind failed remyelination in MS

Study provides new way to treat multiple sclerosis

Study provides new way to treat multiple sclerosis

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Environmental conditions may drive development of multiple sclerosis

Environmental conditions may drive development of multiple sclerosis

Alexion announces positive results from Phase 3 PREVENT study of Soliris in patients with NMOSD

Alexion announces positive results from Phase 3 PREVENT study of Soliris in patients with NMOSD

Researchers discover new subtype of multiple sclerosis

Researchers discover new subtype of multiple sclerosis

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Leukemia itself may increase risk for long-term neurocognitive problems in survivors

Leukemia itself may increase risk for long-term neurocognitive problems in survivors

Popular allergy drug may reduce relapses in patients with neuromyelitis optica

Popular allergy drug may reduce relapses in patients with neuromyelitis optica

Researchers use novel PET tracer to assess myelin damage in mouse models of MS

Researchers use novel PET tracer to assess myelin damage in mouse models of MS